Sabinsa has developed C3 Reduct®, a curcuminoids-based ingredient that has been scientifically shown to boost organ health and deliver a range of other targeted functionalities. This makes it ideal to help manufacturers meet consumer health and wellness expectations – and tap new opportunities in growing markets such as sports nutrition.
Curcumin C3 Reduct®, is the only reductive metabolites of curcuminoids on the market to have been approved as a Novel Food by the European Food Safety Authority (EFSA). Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct® has been shown to boost organ health and deliver a range of other targeted functionalities.
For more information about Sabinsa's C3 Reduct®, visit www.c3reduct.eu